When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

膀胱癌

最后审阅: 1 Nov 2024
最后更新: 08 Dec 2023

小结

定义

病史和体格检查

关键诊断因素

  • 存在的危险因素
  • 血尿(肉眼或镜下)
完整详情

其他诊断因素

  • 尿频
  • 排尿困难
完整详情

危险因素

  • 烟草暴露
  • 接触化学致癌剂
  • 年龄>65 岁
  • 盆腔放疗
  • 全身化疗
  • 血吸虫感染
  • 男性
  • 慢性膀胱炎症
  • 遗传易感性
  • 糖尿病
完整详情

诊断性检查

首要检查

  • 尿液分析
完整详情

需考虑的检查

  • 膀胱镜检查
  • 尿液细胞学检查
  • CT 尿路造影
  • 核磁共振尿路造影
  • 肾脏和膀胱超声
  • 全血细胞计数(FBC)
  • 生化检查(包括碱性磷酸酶)
  • 胸部 X 线检查(CXR)
  • 腹部和盆腔 CT
  • 腹部和盆腔 MRI
  • 氟代脱氧葡萄糖(FDG)-PET/CT
  • 骨扫描
  • 尿液生物标志物
完整详情

治疗流程

急症处理

非肌层浸润性肿瘤

局部浸润性肿瘤

转移性疾病

撰稿人

作者

Joshua J. Meeks, MD, PhD

Associate Professor of Urology

Northwestern University Feinberg School of Medicine

Chicago

IL

利益声明

JJM is a consultant for Merck, AstraZeneca, Incyte, Janssen, BMS, UroGen, Prokarium, Imvax, Pfizer, and Seagen/Astellas. He has received research funding from the VHA, NIH, and DoD; compensation for talks/educational courses from the AUA, OncLive, Olympus, and UroToday; and clinical trial support from SWOG, Genentech, Merck, AstraZeneca, and Incyte. JJM holds patents on T1 and TCGA classifiers; these are not currently available for use in clinical practice. JJM is an author of a reference cited in this topic.

David VanderWeele, MD, PhD

Associate Professor, Hematology and Oncology

Northwestern University Feinberg School of Medicine

Chicago

IL

利益声明

DVW declares that he has received payments from Clovis Oncology, Exelixis, Janssen, and Bayer for advisory boards; research payments from AstraZeneca for clinical trials; payments from Astellas and Myovant for lectures; and payments from Exelixis and AstraZeneca for travel and dinner costs.

​Sarah E. Fenton, MD, PhD

Assistant Professor, Hematology and Oncology

Northwestern University Feinberg School of Medicine

Chicago

IL

利益声明

SEF declares that she has no competing interests.

鸣谢

Dr Joshua J. Meeks, Dr David VanderWeele, and Dr Sarah E. Fenton would like to gratefully acknowledge Dr Donald Lamm and Dr Mary Heeley, previous contributors to this topic.

利益声明

DL is an author of a number of references cited in this topic. MH declares that she has no competing interests.

同行评议者

Junaid Masood, MBBS, FRCS (Eng), MSc (Urol), FRCS (Urol)

Consultant Urological Surgeon

Homerton University Hospital NHS Foundation Trust

London

UK

利益声明

JM declares that he has no competing interests.

Hugh Mostafid, MD

Consultant Urologist

North Hampshire Hospital

Basingstoke

UK

利益声明

HM has received honoraria from GE Healthcare and Kyowa Kirin UK.

Thomas Guzzo, MD

Clinical Instructor of Urology

The James Buchanan Brady Urologic Institute

The Johns Hopkins Medical Institutions

Baltimore

MD

利益声明

TG declares that he has no competing interests.

Amir Kaisary, MD, MA, ChM, FRCS

Consultant Urological Surgeon

Honorary Senior Lecturer

Department of Urology

The Royal Free & University College Medical School

London

UK

利益声明

AK declares that he has no competing interests.

内容使用需遵循免责声明